Postprandial dysmetabolism and large-vessel disease

Area of Science:

• Endocrinology
• Cardiology
• Metabolic Disorders

Background:

• Type 2 diabetes mellitus (T2DM) is linked to increased cardiovascular disease (CVD) morbidity and mortality.
• This risk is not fully explained by traditional risk factors and is often attributed to poor glycemic control.
• Both fasting and postprandial hyperglycemia are identified as significant predictors of CVD in T2DM and prediabetic states.

Purpose of the Study:

• To review the relationship between glycemia, particularly postprandial glucose, and CVD in T2DM and impaired glucose tolerance.
• To explore potential mechanisms linking postprandial hyperglycemia to cardiovascular disease development.

Main Methods:

• Review of epidemiological studies and clinical trial data.
• Analysis of the association between fasting blood glucose (FBG), post-challenge hyperglycemia, and CVD outcomes.
• Examination of evidence regarding the impact of intensive glycemic control on CVD risk in T2DM.

Main Results:

• Post-challenge hyperglycemia is a strong predictor of CVD mortality in impaired glucose tolerance, independent of FBG.
• The relationship between FBG and CVD is influenced by post-challenge glycemic levels.
• While some studies show benefits of intensive insulin therapy on CVD outcomes in specific T2DM populations, overall evidence for significant CVD risk reduction through improved glycemic control is lacking.

Conclusions:

• Postprandial hyperglycemia plays a critical role in the elevated cardiovascular disease risk associated with Type 2 diabetes.
• Further research is needed to elucidate the mechanisms and confirm the benefits of targeting postprandial glucose for cardiovascular risk reduction in T2DM.